The Incidence of Rectal Neuroendocrine Tumors Is Increasing in Younger Adults in the US, 2001–2020

Prior non-comparative data showed increasing incidence of rectal neuroendocrine tumors (RNET) in the US. We aimed to evaluate age-specific RNET incidence rates and time-trends in demographic- and tumor-specific populations. The RNET age-adjusted incidence rates were calculated from the United States...

Full description

Bibliographic Details
Main Authors: Yazan Abboud, Navya Pendyala, Alexander Le, Anmol Mittal, Saqr Alsakarneh, Fouad Jaber, Kaveh Hajifathalian
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/21/5286
_version_ 1797632060550021120
author Yazan Abboud
Navya Pendyala
Alexander Le
Anmol Mittal
Saqr Alsakarneh
Fouad Jaber
Kaveh Hajifathalian
author_facet Yazan Abboud
Navya Pendyala
Alexander Le
Anmol Mittal
Saqr Alsakarneh
Fouad Jaber
Kaveh Hajifathalian
author_sort Yazan Abboud
collection DOAJ
description Prior non-comparative data showed increasing incidence of rectal neuroendocrine tumors (RNET) in the US. We aimed to evaluate age-specific RNET incidence rates and time-trends in demographic- and tumor-specific populations. The RNET age-adjusted incidence rates were calculated from the United States Cancer Statistics (USCS) database between 2001 and 2020. The population was stratified by age into older (<inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mo>≥</mo></mrow></semantics></math></inline-formula>55 years) and younger adults (<55 years), as well as by sex and race. The tumors were categorized by their stage at diagnosis into early and late. The annual percentage change (APC) and average APC (AAPC) were estimated using joinpoint regression and Monte Carlo permutation analysis. Pairwise comparison assessed for parallelism and coincidence. There were 59,846 patients diagnosed with RNET between 2001 and 2020 (50.3% women). Overall, the RNET incidence rates during this period were increasing in younger but not older adults (AAPC = 3.12 vs. −1.10; AAPC difference = 4.22, <i>p</i> < 0.001), with non-identical non-parallel data (<i>p</i>-values < 0.001). While similar results were seen in men, a greater age-specific difference was noted in women (AAPC = 3.31 vs. −1.10; AAPC difference = 4.41, <i>p</i> = 0.003). The difference between younger and older adults was seen in non-Hispanic White (AAPC-difference = 4.89; <i>p</i> < 0.001) and non-Hispanic Black (AAPC-difference = 3.33; <i>p</i> = 0.03) patients, and, in most years, among Hispanic and Non-Hispanic Asian/Pacific Islander patients, and it was mostly driven by early-stage tumors (AAPC-difference = 3.93; <i>p</i> < 0.001). The nationwide data show a significantly increasing RNET incidence in younger adults, most notably in younger women and in early-stage tumors, seen in various races. Future studies should evaluate RNET risk factors and outcomes in demographic-specific populations.
first_indexed 2024-03-11T11:32:33Z
format Article
id doaj.art-55716a57af1c46f192f74b7f66dfc2b4
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T11:32:33Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-55716a57af1c46f192f74b7f66dfc2b42023-11-10T15:00:30ZengMDPI AGCancers2072-66942023-11-011521528610.3390/cancers15215286The Incidence of Rectal Neuroendocrine Tumors Is Increasing in Younger Adults in the US, 2001–2020Yazan Abboud0Navya Pendyala1Alexander Le2Anmol Mittal3Saqr Alsakarneh4Fouad Jaber5Kaveh Hajifathalian6Department of Internal Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USADepartment of Internal Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USADepartment of Internal Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USADepartment of Internal Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USADepartment of Internal Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USADepartment of Internal Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USADivision of Gastroenterology and Hepatology, Rutgers New Jersey Medical School, Newark, NJ 07103, USAPrior non-comparative data showed increasing incidence of rectal neuroendocrine tumors (RNET) in the US. We aimed to evaluate age-specific RNET incidence rates and time-trends in demographic- and tumor-specific populations. The RNET age-adjusted incidence rates were calculated from the United States Cancer Statistics (USCS) database between 2001 and 2020. The population was stratified by age into older (<inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mo>≥</mo></mrow></semantics></math></inline-formula>55 years) and younger adults (<55 years), as well as by sex and race. The tumors were categorized by their stage at diagnosis into early and late. The annual percentage change (APC) and average APC (AAPC) were estimated using joinpoint regression and Monte Carlo permutation analysis. Pairwise comparison assessed for parallelism and coincidence. There were 59,846 patients diagnosed with RNET between 2001 and 2020 (50.3% women). Overall, the RNET incidence rates during this period were increasing in younger but not older adults (AAPC = 3.12 vs. −1.10; AAPC difference = 4.22, <i>p</i> < 0.001), with non-identical non-parallel data (<i>p</i>-values < 0.001). While similar results were seen in men, a greater age-specific difference was noted in women (AAPC = 3.31 vs. −1.10; AAPC difference = 4.41, <i>p</i> = 0.003). The difference between younger and older adults was seen in non-Hispanic White (AAPC-difference = 4.89; <i>p</i> < 0.001) and non-Hispanic Black (AAPC-difference = 3.33; <i>p</i> = 0.03) patients, and, in most years, among Hispanic and Non-Hispanic Asian/Pacific Islander patients, and it was mostly driven by early-stage tumors (AAPC-difference = 3.93; <i>p</i> < 0.001). The nationwide data show a significantly increasing RNET incidence in younger adults, most notably in younger women and in early-stage tumors, seen in various races. Future studies should evaluate RNET risk factors and outcomes in demographic-specific populations.https://www.mdpi.com/2072-6694/15/21/5286rectal neuroendocrine tumorsincidenceepidemiologyrectal cancerhealth disparityneuroendocrine tumors
spellingShingle Yazan Abboud
Navya Pendyala
Alexander Le
Anmol Mittal
Saqr Alsakarneh
Fouad Jaber
Kaveh Hajifathalian
The Incidence of Rectal Neuroendocrine Tumors Is Increasing in Younger Adults in the US, 2001–2020
Cancers
rectal neuroendocrine tumors
incidence
epidemiology
rectal cancer
health disparity
neuroendocrine tumors
title The Incidence of Rectal Neuroendocrine Tumors Is Increasing in Younger Adults in the US, 2001–2020
title_full The Incidence of Rectal Neuroendocrine Tumors Is Increasing in Younger Adults in the US, 2001–2020
title_fullStr The Incidence of Rectal Neuroendocrine Tumors Is Increasing in Younger Adults in the US, 2001–2020
title_full_unstemmed The Incidence of Rectal Neuroendocrine Tumors Is Increasing in Younger Adults in the US, 2001–2020
title_short The Incidence of Rectal Neuroendocrine Tumors Is Increasing in Younger Adults in the US, 2001–2020
title_sort incidence of rectal neuroendocrine tumors is increasing in younger adults in the us 2001 2020
topic rectal neuroendocrine tumors
incidence
epidemiology
rectal cancer
health disparity
neuroendocrine tumors
url https://www.mdpi.com/2072-6694/15/21/5286
work_keys_str_mv AT yazanabboud theincidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020
AT navyapendyala theincidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020
AT alexanderle theincidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020
AT anmolmittal theincidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020
AT saqralsakarneh theincidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020
AT fouadjaber theincidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020
AT kavehhajifathalian theincidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020
AT yazanabboud incidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020
AT navyapendyala incidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020
AT alexanderle incidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020
AT anmolmittal incidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020
AT saqralsakarneh incidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020
AT fouadjaber incidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020
AT kavehhajifathalian incidenceofrectalneuroendocrinetumorsisincreasinginyoungeradultsintheus20012020